Evaluating the Safety Profile of Ticagrelor: Insights from Literature and Database Analysis

• by Renzhu Liu, Lu Xiao, Qingzi Yan, Xiang Liu

• February 2, 2026

Forecasting Atrial Fibrillation Following Acute Coronary Syndrome: Findings from the BACS and BAMI Studies

• by Jaime Francisco Larre-Guerra, Álvaro Castrillo-Capilla, Macarena Garbayo-Bugeda, Andrea Kallmeyer, Ester Cánovas, María Nieves Tarín, Carmen Cristóbal, Ana Huelmos, Carlos Gutiérrez-Landaluce, José Antonio Esteban Chapel, Junior Senra, María Luisa González Casaus, Joaquín Alonso, Lorenzo López-Bescós, Ignacio Mahíllo, Óscar Lorenzo, José Manuel Rubio-Campal, José Tuñón

• April 20, 2026

Type 1 and type 2 NSTEMI in atrial fibrillation: insights from the HERA-FIB registry

• by Mustafa Yildirim, Christian Salbach, Johannes Dürr, Matthias Mueller-Hennessen, Hugo A. Katus, Norbert Frey, Evangelos Giannitsis

• April 15, 2026

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

• by Kerri Miller

• April 16, 2026

• 3 min